• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结肠菌群、益生菌、肥胖和糖尿病。

Colonic flora, probiotics, obesity and diabetes.

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Eastern Virginia Medical School, Norfolk, VA, USA.

出版信息

Front Endocrinol (Lausanne). 2012 Jul 11;3:87. doi: 10.3389/fendo.2012.00087. eCollection 2012.

DOI:10.3389/fendo.2012.00087
PMID:22798958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3393882/
Abstract

Obesity results from alterations in the body's regulation of energy intake, expenditure, and storage. Animal and human data demonstrate that phylogenic changes occur in the microbiota composition in obese individuals. Furthermore, evidence from animal models suggest that the alterations of the gut microbiota with obesity results in increased energy extraction and lipid deposition, altered release of entero-hormones, increased intestinal permeability and metabolic endotoxemia. Treatment with pre- and probiotics may reverse many of metabolic effects linked with the altered microbiota in obese patients. The gut microbiota is, therefore, a potential nutritional and pharmacological target for the management of obesity and obesity-related disorders.

摘要

肥胖是由于机体能量摄入、消耗和储存的调节发生改变所致。动物和人类研究资料均表明,肥胖个体的微生物组成发生了种系发生变化。此外,动物模型研究证据提示,肥胖导致肠道微生物群改变,从而增加能量提取和脂质沉积,改变肠促激素释放,增加肠道通透性和代谢性内毒素血症。应用益生菌和益生元治疗可能逆转与肥胖患者微生物群改变相关的许多代谢效应。因此,肠道微生物群是肥胖及其相关疾病管理的一个有潜力的营养和药理学治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ef7/3393882/5edd89de4f8d/fendo-03-00087-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ef7/3393882/5edd89de4f8d/fendo-03-00087-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ef7/3393882/5edd89de4f8d/fendo-03-00087-g001.jpg

相似文献

1
Colonic flora, probiotics, obesity and diabetes.结肠菌群、益生菌、肥胖和糖尿病。
Front Endocrinol (Lausanne). 2012 Jul 11;3:87. doi: 10.3389/fendo.2012.00087. eCollection 2012.
2
Gut microbiota and its possible relationship with obesity.肠道微生物群及其与肥胖的潜在关系。
Mayo Clin Proc. 2008 Apr;83(4):460-9. doi: 10.4065/83.4.460.
3
The gut microbiota, obesity and insulin resistance.肠道微生物群、肥胖和胰岛素抵抗。
Mol Aspects Med. 2013 Feb;34(1):39-58. doi: 10.1016/j.mam.2012.11.001. Epub 2012 Nov 16.
4
Interplay of Gut Microbiota, Probiotics in Obesity: A Review.肠道微生物群与益生菌在肥胖中的相互作用:综述
Endocr Metab Immune Disord Drug Targets. 2018;18(3):212-220. doi: 10.2174/1871530318666180131092203.
5
The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: a randomized double-blind controlled clinical trial.益生菌与草药联合应用对肥胖、代谢性内毒素血症和肠道菌群失调的影响:一项随机、双盲、对照的临床试验。
Clin Nutr. 2014 Dec;33(6):973-81. doi: 10.1016/j.clnu.2013.12.006. Epub 2013 Dec 31.
6
Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.肠道微生物群、肠道通透性、肥胖引起的炎症和肝损伤。
JPEN J Parenter Enteral Nutr. 2011 Sep;35(5 Suppl):14S-20S. doi: 10.1177/0148607111413772. Epub 2011 Aug 1.
7
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability.肠道微生物群的变化通过一种涉及胰高血糖素样肽-2驱动的肠道通透性改善的机制来控制肥胖小鼠的炎症。
Gut. 2009 Aug;58(8):1091-103. doi: 10.1136/gut.2008.165886. Epub 2009 Feb 24.
8
The development of probiotics therapy to obesity: a therapy that has gained considerable momentum.益生菌疗法治疗肥胖症的发展:一种备受关注的疗法。
Hormones (Athens). 2018 Jun;17(2):141-151. doi: 10.1007/s42000-018-0003-y. Epub 2018 Apr 16.
9
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.肠道微生物群的变化控制高脂饮食诱导的小鼠肥胖和糖尿病中代谢性内毒素血症引发的炎症。
Diabetes. 2008 Jun;57(6):1470-81. doi: 10.2337/db07-1403. Epub 2008 Feb 27.
10
Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?肠道微生物群与肥胖、胰岛素抵抗和 2 型糖尿病的相互作用:肠道微生物群是否与胰岛素抵抗共同进化?
Curr Opin Clin Nutr Metab Care. 2011 Sep;14(5):483-90. doi: 10.1097/MCO.0b013e328348c06d.

引用本文的文献

1
The effect of probiotic-fortified kefir on depression, appetite, oxidative stress, and inflammatory parameters in Iranian overweight and obese elderly: a randomized, double-blind, placebo-controlled clinical trial.益生菌强化开菲尔对伊朗超重和肥胖老年人抑郁、食欲、氧化应激及炎症参数的影响:一项随机、双盲、安慰剂对照临床试验
J Health Popul Nutr. 2025 Feb 7;44(1):30. doi: 10.1186/s41043-025-00773-x.
2
The effect of supplementation in pregnant women with low-grade inflammation.对患有轻度炎症的孕妇进行补充的效果。
Food Sci Nutr. 2023 Oct 16;12(1):292-297. doi: 10.1002/fsn3.3759. eCollection 2024 Jan.
3
Heat-Killed GMNL-653 Exerts Antiosteoporotic Effects by Restoring the Gut Microbiota Dysbiosis in Ovariectomized Mice.

本文引用的文献

1
Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis.益生菌预防和治疗抗生素相关性腹泻:系统评价和荟萃分析。
JAMA. 2012 May 9;307(18):1959-69. doi: 10.1001/jama.2012.3507.
2
Bariatric surgery versus intensive medical therapy in obese patients with diabetes.肥胖伴糖尿病患者的减肥手术与强化内科治疗的比较。
N Engl J Med. 2012 Apr 26;366(17):1567-76. doi: 10.1056/NEJMoa1200225. Epub 2012 Mar 26.
3
Bariatric surgery versus conventional medical therapy for type 2 diabetes.
热灭活的GMNL-653通过恢复去卵巢小鼠的肠道微生物群失调发挥抗骨质疏松作用。
Front Nutr. 2022 Feb 4;9:804210. doi: 10.3389/fnut.2022.804210. eCollection 2022.
4
The role of gut microbiota in bone homeostasis.肠道微生物群在骨骼稳态中的作用。
Bone Joint Res. 2021 Jan;10(1):51-59. doi: 10.1302/2046-3758.101.BJR-2020-0273.R1.
5
Gut microbiota, probiotics and diabetes.肠道微生物群、益生菌与糖尿病
Nutr J. 2014 Jun 17;13:60. doi: 10.1186/1475-2891-13-60.
6
Intake of Blueberry Fermented by Lactobacillus plantarum Affects the Gut Microbiota of L-NAME Treated Rats.鼠李糖乳杆菌发酵蓝莓对 L-NAME 处理大鼠肠道微生物群的影响。
Evid Based Complement Alternat Med. 2013;2013:809128. doi: 10.1155/2013/809128. Epub 2013 Apr 9.
7
Diet affects symptoms and medication response in inflammatory bowel disease.饮食会影响炎症性肠病的症状及药物反应。
Dig Dis Sci. 2013 May;58(5):1173-4. doi: 10.1007/s10620-013-2619-8.
减重手术与常规药物疗法治疗 2 型糖尿病的疗效比较。
N Engl J Med. 2012 Apr 26;366(17):1577-85. doi: 10.1056/NEJMoa1200111. Epub 2012 Mar 26.
4
The influence of milk oligosaccharides on microbiota of infants: opportunities for formulas.牛奶低聚糖对婴儿肠道菌群的影响:配方奶粉的机遇。
Annu Rev Food Sci Technol. 2011;2:331-51. doi: 10.1146/annurev-food-022510-133743.
5
Benefits of bariatric surgery: an issue of microbial-host metabolism interactions?减重手术的益处:微生物与宿主代谢相互作用的问题?
Gut. 2011 Sep;60(9):1166-7. doi: 10.1136/gut.2011.242503. Epub 2011 May 16.
6
Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk.代谢手术深刻影响肠道微生物-宿主代谢相互作用。
Gut. 2011 Sep;60(9):1214-23. doi: 10.1136/gut.2010.234708. Epub 2011 May 14.
7
Gut microbiota and the pathogenesis of insulin resistance.肠道微生物群与胰岛素抵抗的发病机制。
Curr Diab Rep. 2011 Jun;11(3):154-9. doi: 10.1007/s11892-011-0191-1.
8
Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy.母亲体重对婴儿早期肠道菌群获得、组成和活性的影响:一项在早孕时启动的前瞻性随访研究。
Am J Clin Nutr. 2010 Nov;92(5):1023-30. doi: 10.3945/ajcn.2010.29877. Epub 2010 Sep 15.
9
Functional intestinal microbiome, new frontiers in prebiotic design.功能性肠道微生物组:益生元设计的新前沿。
Int J Food Microbiol. 2010 Jun 15;140(2-3):93-101. doi: 10.1016/j.ijfoodmicro.2010.04.017. Epub 2010 Apr 24.
10
The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years.围产期益生菌干预对超重和肥胖发展的影响:从出生到 10 年的随访研究。
Int J Obes (Lond). 2010 Oct;34(10):1531-7. doi: 10.1038/ijo.2010.50. Epub 2010 Mar 16.